Injective (INJ) is attempting to regain a key technical trendline after posting a strong daily recovery, with analysts watching whether buyers can sustain the momentum. While forecasts point to moderate upside, the next move will likely depend on whether INJ reclaims resistance or revisits lower support levels.
